Go to deals
Software & Technology

PCI Pal has completed an equity raise

PCI Pal has completed a fundraising. Funds will be allocated towards several key areas, with a significant portion directed towards supporting its continued expansion in the US, focusing on marketing efforts, product marketing and enhancing engagement with key partners.

PCI Pal is a global provider of secure payment solutions. PCI Pal’s globally accessible cloud platform empowers organizations to take cardholder-not-present payments securely without bringing their environments into scope of PCI DSS and other card payment data security rules and regulations.

Oaklins Cavendish, based in the UK, closed a heavily oversubscribed US$4.5 million equity raise for PCI Pal.

Talk to the deal team

Marc Milmo

Director
London, United Kingdom
Oaklins Cavendish

Related deals

Niscon Inc. has been acquired by SGPS ShowRig
Broadcasting, Streaming & Entertainment | Events | Software & Technology

Niscon Inc. has been acquired by SGPS ShowRig

Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.

Learn more
OSL has been acquired by Terma
Software & Technology

OSL has been acquired by Terma

OSL Group Limited, a leader in counter-drone security and safety systems, has been acquired by Terma AS, a Denmark-based global provider of mission-critical solutions for defense, aerospace and security.

Learn more
Banook, backed by Motion Equity, has acquired Fluidda
Healthcare Communications & Technology | Software & Technology

Banook, backed by Motion Equity, has acquired Fluidda

Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.

Learn more